U.S. Formulation Development Outsourcing Market Size & Outlook

The formulation development outsourcing market in the United States is expected to reach a projected revenue of US$ 13,801.1 million by 2030. A compound annual growth rate of 5.8% is expected of the United States formulation development outsourcing market from 2024 to 2030.
Revenue, 2023 (US$M)
$9,287.5
Forecast, 2030 (US$M)
$13,801.1
CAGR, 2024 - 2030
5.8%
Report Coverage
U.S.

U.S. formulation development outsourcing market, 2018-2030 (US$M)

U.S.

Related Markets

U.S. formulation development outsourcing market highlights

  • The U.S. formulation development outsourcing market generated a revenue of USD 9,287.5 million in 2023 and is expected to reach USD 13,801.1 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 5.8% from 2024 to 2030.
  • In terms of segment, formulation development was the largest revenue generating service in 2023.
  • Formulation Development is the most lucrative service segment registering the fastest growth during the forecast period.

Formulation development outsourcing market data book summary

Market revenue in 2023USD 9,287.5 million
Market revenue in 2030USD 13,801.1 million
Growth rate5.8% (CAGR from 2023 to 2030)
Largest segmentFormulation development
Fastest growing segmentFormulation Development
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPreformulation, Formulation Development
Key market players worldwideSGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc

Other key industry trends

  • In terms of revenue, U.S. accounted for 24.5% of the global formulation development outsourcing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. formulation development outsourcing market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 1,048.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Formulation Development Outsourcing Market Scope

Formulation development outsourcing market segmentation & scope
Preformulation
Formulation Development
Oral
Injectable
Topical
Others
Oncology
Infectious disease
Neurology
Hematology
Respiratory
Cardiovascular
Dermatology
Others

Formulation Development Outsourcing Market Companies

Name Profile # Employees HQ Website

U.S. formulation development outsourcing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.


Formulation development was the largest segment with a revenue share of 76.81% in 2023. Horizon Databook has segmented the U.S. formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.


The U.S. accounts for a major share of clinical trial recruitment across the globe, with 20,781 trial studies being recruited within the country as of March 2023, according to clinicaltrails.gov. Along with branded and patented drug products, there is a strong demand for cost-effective generic and biosimilar compounds in this region.

For instance, according to a report published by Cardinal Health, in January 2022, around 33 FDA-approved biosimilars were available in the U.S., 21 of which were commercially available in the market. Thus, the increasing development and approval of novel biosimilars are expected to propel the demand for formulation development processes & outsourcing activities in the U.S., largely driving the market.

Furthermore, the country is reported to have a large population suffering from heart disease, with one person dying every 34 seconds, according to the Centers for Disease Control and Prevention. This raises the demand for effective therapeutic drugs with better bioavailability, which expands the opportunities for formulation development outsourcers.

Reasons to subscribe to U.S. formulation development outsourcing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. formulation development outsourcing market databook

  • Our clientele includes a mix of formulation development outsourcing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. formulation development outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. formulation development outsourcing market size, by service, 2018-2030 (US$M)

U.S. Formulation Development Outsourcing Market Outlook Share, 2023 & 2030 (US$M)

U.S. formulation development outsourcing market size, by service, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more